BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10462129)

  • 1. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors.
    Carli M; Silva S; Balducci C; Samanin R
    Neuropharmacology; 1999 Aug; 38(8):1165-73. PubMed ID: 10462129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats.
    Carli M; Balducci C; Samanin R
    Psychopharmacology (Berl); 2001 Oct; 158(1):39-47. PubMed ID: 11685382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid.
    Carli M; Bonalumi P; Samanin R
    Brain Res; 1997 Nov; 774(1-2):167-74. PubMed ID: 9452205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of 5-HT1A receptors in the dorsal raphe reverses the impairment of spatial learning caused by intrahippocampal scopolamine in rats.
    Carli M; Bonalumi P; Samanin R
    Eur J Neurosci; 1998 Jan; 10(1):221-30. PubMed ID: 9753130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.
    Carli M; Balducci C; Millan MJ; Bonalumi P; Samanin R
    Br J Pharmacol; 1999 Nov; 128(6):1207-14. PubMed ID: 10578133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe.
    Carli M; Balducci C; Samanin R
    Br J Pharmacol; 2000 Sep; 131(2):375-81. PubMed ID: 10991934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of 5-HT1A receptors compensates loss of hippocampal cholinergic neurotransmission involved in working memory of rats.
    Ohno M; Watanabe S
    Brain Res; 1996 Oct; 736(1-2):180-8. PubMed ID: 8930323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.
    Carli M; Luschi R; Samanin R
    Eur J Pharmacol; 1995 Sep; 283(1-3):133-9. PubMed ID: 7498302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.
    Mirjana C; Baviera M; Invernizzi RW; Balducci C
    Neuropsychopharmacology; 2004 Sep; 29(9):1637-47. PubMed ID: 15127084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic dysfunction exacerbates impairment of working memory induced by hippocampal NMDA receptor blockade in rats.
    Ohno M; Yoshimatsu A; Kobayashi M; Watanabe S
    Eur J Pharmacol; 1996 Jun; 307(1):21-6. PubMed ID: 8831099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of 5-HT3 receptor antagonism on working memory failure due to deficiency of hippocampal cholinergic and glutamatergic transmission in rats.
    Ohno M; Watanabe S
    Brain Res; 1997 Jul; 762(1-2):211-5. PubMed ID: 9262175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent blockade of hippocampal metabotropic glutamate and N-methyl-D-aspartate receptors disrupts working memory in the rat.
    Ohno M; Watanabe S
    Neuroscience; 1996 Jan; 70(2):303-11. PubMed ID: 8848141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine blockade of MK-801-induced learning/memory impairment in the mEPM: Role of 5-HT
    López Hill X; Richeri A; Scorza MC
    Physiol Behav; 2017 Oct; 179():346-352. PubMed ID: 28705535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
    Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
    Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.
    Carli M; Samanin R
    Psychopharmacology (Berl); 2000 Apr; 149(3):259-68. PubMed ID: 10823407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist.
    Carli M; Luschi R; Samanin R
    Behav Brain Res; 1997 Jan; 82(2):185-94. PubMed ID: 9030400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.
    Ceglia I; Carli M; Baviera M; Renoldi G; Calcagno E; Invernizzi RW
    J Neurochem; 2004 Oct; 91(1):189-99. PubMed ID: 15379899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
    Carli M; Baviera M; Invernizzi RW; Balducci C
    Neuropsychopharmacology; 2006 Apr; 31(4):757-67. PubMed ID: 16192987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
    Calcagno E; Carli M; Baviera M; Invernizzi RW
    J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA-receptor blockade by CPP impairs post-training consolidation of a rapidly acquired spatial representation in rat hippocampus.
    McDonald RJ; Hong NS; Craig LA; Holahan MR; Louis M; Muller RU
    Eur J Neurosci; 2005 Sep; 22(5):1201-13. PubMed ID: 16176363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.